The word chelate is derived from the Greek word chele, which refers to the claw of a crab or lobster, implying a strong binding action by the chelating agent to another free radical compound. Chelation therapy involves administering specific agents (orally or intravenously) to bind toxic compounds in the blood or tissues of the body. The process of removing free radical and toxic metals is known as Chelation Therapy. Chelation therapy is most effective when administered by the intravenous route. The origin of chelation therapy dates back to 1940, when it was first used to treat lead poisoning using a chelating agent known as EDTA and used along with other antioxidants which improve blood flow and improves cardiac and general health as well. Chelation therapy is also known to increase collateral or micro circulation in coronary arteries. Chelation therapy decreases global blood flow deficiency index.
Conditions | Conditions |
---|---|
Cataract, Diab. Retinopathy, Glaucoma, Macular Degeneration | Alzheimer's Disease, Cerebrovascular Disease, Dementia, Headache, Multiple Sclerosis, Parkinson's Disease, Stroke, Vertigo |
Chronic Obstructive Pulmonary Disease | Angina, Arrhythmia, Cardiomyopathy, Congestive Heart failure, Coronary Artery Disease, High Blood Pressure, Vascular Disease |
Cirrhosis of Liver, Hypercholesterolemia | Kidney Disease |
Bursitis | Osteoporosis, Osteoarthritis |
Peripheral Vascular Disease | Gangrene, Raynaud's Disease Buerger's Disease |
Diabetes Mellitus | Diabetic Neuropathy |
Digitalis Poisoning | Fatigue, Fibromyalgia |
Heavy Metal Poisoning | Lupus Erythematosus |
Rheumatoid Arthritis | Scleroderma |